Path Forward 6 : Basic vaccine questions still go unanswered despite rollout

And even if reinfection is “a thing,” it appears to be much less severe the second time people get the virus, said Andrew Noymer, an epidemiologist and population health scientist at UC Irvine. “But will the vaccine protection be comparable to having survived natural infection? Nobody knows yet. It may even be superior.”